Tiny brain tumors often hide in plain sight—sometimes no bigger than a grain of rice. These metastases, or secondary cancers that spread from other parts of the body, are especially dangerous. They ...

Neosoma, a best-in-class provider of AI-based brain tumor analysis medical software, receives FDA 510(k) clearance for its Brain Mets product. This clearance ushers in a new era in the assessment of ...

OpEd: Multicancer early detection is the next frontier in cancer prevention and treatment, and it needs to be adopted widely.

The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...

The CATNON trial showed adjuvant Temodar benefits grade 3 glioma patients, with no added benefit from concurrent chemotherapy, reducing potential toxicity. HER3-DXd, an antibody-drug conjugate, ...

While earlier detection improves outcomes, it does not reduce costs. Cancer treatment typically involves repeated ...

Brain cancer can occur at any age, but it's most common in children under 15 and adults over 65. Nowadays it is striking people under the age of 40. A brain tumor is an abnormal, uncontrolled growth ...

Childhood cancers are relatively rare compared to adult cancers, but they remain a significant health concern because they often develop suddenly and progress quickly. Mostly, childhood cancers – ...